Clare Market Investments LLC acquired a new stake in shares of Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 5,350 shares of the basic materials company’s stock, valued at approximately $581,000.
Other large investors also recently bought and sold shares of the company. Nisa Investment Advisors LLC acquired a new position in Cameco during the fourth quarter valued at approximately $25,000. Founders Capital Management acquired a new position in Cameco during the 4th quarter worth $27,000. Strategic Advocates LLC acquired a new position in Cameco in the third quarter worth $28,000. Mcguire Capital Advisors Inc. acquired a new stake in shares of Cameco during the fourth quarter worth $28,000. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in shares of Cameco by 30,700.0% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 308 shares of the basic materials company’s stock valued at $28,000 after buying an additional 307 shares during the period. Hedge funds and other institutional investors own 70.21% of the company’s stock.
Cameco Stock Down 2.2%
Cameco stock opened at $95.38 on Tuesday. The firm has a market capitalization of $41.54 billion, a price-to-earnings ratio of 88.02, a PEG ratio of 1.76 and a beta of 1.02. The company’s 50 day simple moving average is $108.73 and its 200 day simple moving average is $110.75. The company has a debt-to-equity ratio of 0.14, a current ratio of 3.08 and a quick ratio of 2.09. Cameco Corporation has a fifty-two week low of $68.96 and a fifty-two week high of $135.24.
Wall Street Analyst Weigh In
A number of brokerages have recently weighed in on CCJ. Royal Bank Of Canada increased their price target on Cameco from $160.00 to $175.00 and gave the stock an “outperform” rating in a research report on Monday, June 29th. Canadian Imperial Bank of Commerce lifted their price objective on shares of Cameco to $202.00 in a research report on Monday, March 9th. TD Securities cut shares of Cameco from a “strong-buy” rating to a “hold” rating in a research report on Thursday, March 26th. William Blair started coverage on Cameco in a report on Monday, April 20th. They set an “outperform” rating on the stock. Finally, Barclays started coverage on Cameco in a research report on Thursday, May 21st. They issued an “equal weight” rating and a $108.00 target price on the stock. Eleven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $148.92.
Get Our Latest Research Report on Cameco
Cameco Profile
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Further Reading
- Five stocks we like better than Cameco
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
- 2 Short Squeezes for Summer Speculation: What the Bears Are Getting Wrong
- How TeraWulf’s Anthropic Deal Booted Up a $19B AI Empire
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
